自然化合物向编程细胞死亡 (PCD) 信号机制来治疗性结肠炎:一篇评论
Bo Chen1, Xinqian Dong2, Jin Long Zhang1
1Shandong University of Traditional Chinese Medicine, Jinan, China.
Frontiers in pharmacology
|February 26, 2024
概括
性结肠炎 (UC) 治疗可以通过向编程细胞死亡 (PCD) 途径来改善. 天然化合物在调节这些途径方面表现有前途,以减少UC患者的炎症和损伤.
科学领域:
- 生物医学科学 生物医学科学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 性结肠炎 (UC) 是一种具有高耐药性和复发率的慢性炎症性肠病.
- 在UC的慢性炎症可以增加结肠癌的风险.
- 编程细胞死亡 (PCD) 途径对于恒温至关重要,它们的调节失调与UC病变产生有关.
研究的目的:
- 审查编程细胞死亡 (PCD) 在性结肠炎 (UC) 中的作用.
- 探索自然化合物如何针对UC治疗的PCD途径.
- 阐明PCD与UC中的关键信号通路之间的相互作用.
主要方法:
- 使用关键词进行文献搜索:性结肠炎,编程细胞死亡和天然产品.
- 搜索的数据库:PubMed,科学网络和CNKI.
- 综述了过去10年发表的72项研究,重点关注过去5年.
主要成果:
- 异常的PCD信号,包括细胞亡,有助于UC的进展.
- 像贝卡林这样的天然化合物在调节PCD以减少UC炎症方面显示出潜力.
- 在UC中,PCD与NF-κB,Nrf2,MAPK,JAK/STAT,PI3K/AKT,NLRP3,GPX4和Bcl-2等信号通路相互作用.
结论:
- 准PCD途径代表了UC的有前途的治疗策略.
- 自然化合物通过调节PCD为开发新型UC治疗提供了可行的方法.
- 对PCD机制和天然产品相互作用的进一步研究可以导致UC的新药开发.
更多相关视频
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
141
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
141
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
119
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
119
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
163
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
163
The Extrinsic Apoptotic Pathway
6.4K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.4K
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K


